TRPC (canonical transient receptor potential) channel subunits have been shown to assemble into homo-or hetero-meric channel complexes, including different Ca 2+ -handling proteins, required for the activation of CCE (capacitative Ca 2+ entry) or NCCE (non-CCE) pathways. In the present study we found evidence for the dynamic interaction between endogenously expressed hTRPC6 (human TRPC6) with either both Orai1 and STIM1 (stromal interaction molecule 1) or hTRPC3 to participate in CCE or NCCE. Electrotransjection of cells with an anti-hTRPC6 antibody, directed towards the C-terminal region, reduces CCE induced by TPEN [N,N,N ,N -tetrakis-(2-pyridylmethyl)-ethylenediamine], which reduces the intraluminal free Ca 2+ concentration. Cell stimulation with thrombin or extensive Ca 2+ -store depletion by TG (thapsigargin) + ionomycin enhanced the interaction between hTRPC6 and the CCE proteins Orai1 and STIM1. In contrast, stimulation with the diacylglycerol analogue OAG (1-oleoyl-2-acetyl-sn-glycerol) displaces hTRPC6 from Orai1 and STIM1 and enhances the association between hTRPC6 and hTRPC3. The interaction between hTRPC6 and hTRPC3 was abolished by dimethyl-BAPTA [1,2-bis-(o-aminophenoxy)ethane-N,N,N ,N -tetra-acetic acid] loading, which indicates that this phenomenon is Ca 2+ -dependent. These findings support the hypothesis that hTRPC6 participates both in CCE and NCCE through its interaction with the Orai1-STIM1 complex or hTRPC3 respectively.
INTRODUCTION
The TRPC (canonical transient receptor potential) cation channels are mammalian homologues of the photoreceptor TRP (transient receptor potential) channel in Drosophila melanogaster [1] . Results from a number of studies have supported the role of TRPC channels in both CCE (capacitative Ca 2+ entry) and NCCE (non-CCE) pathways [2] [3] [4] [5] .
The identification of the ER (endoplasmic reticulum) Ca 2+ sensor STIM1 (stromal interaction molecule 1) and the PM (plasma membrane) Ca 2+ channel Orai1 has shed new light on the mechanism of activation of CCE. Orai1 forms a highly Ca 2+ -selective channel that has been proposed to conduct I CRAC (Ca 2+ release-activated Ca 2+ current) [6] . Orai1 has been reported to participate in the formation of multimeric ion-channel complexes involving hTRPC1 (human TRPC1) and STIM1 [7, 8] . STIM1 is a low-affinity Ca 2+ -binding protein, mostly located in the ER membrane, that contains an EF-hand domain in the N-terminus, located in the lumen of the ER, that has been proposed to function as a Ca 2+ sensor in the ER [9, 10] , conferring TRPC1 protein store-operated sensitivity [8] .
hTRPC6 has been presented as a component of NCCE, as well as CCE, channels. hTRPC6 was initially presented as a channel activated by DAG (diacylglycerol) generated by receptor-induced phospholipase C activation [11, 12] . Furthermore, in human platelets, heteromeric interaction of hTRPC6 with hTRPC1 forms a complex activated by depletion of the intracellular Ca 2+ stores [13] . Consistent with this, we have previously reported that hTRPC6 is required for TG (thapsigargin)-mediated Ca 2+ entry in platelets [4] . In addition, in smooth muscle cells, hTRPC6 channels are activated by mechanical stretch, leading to membrane depolarization and the activation of voltage-dependent Ca 2+ entry [14] . Therefore TRPC6-forming channels function as integrators of a number of intracellular signals.
There is significant controversy concerning the mode of activation (capacitative or non-capacitative) of particular TRPC channel subunits [15] . These discrepancies might at least be partially attributed to the tetrameric composition of TRPC channels. Thus different combinations of TRPC subunits might lead to the formation of channels with different biophysical properties. The assembly of a particular combination of TRPC subunits might be performed in situ under an adequate stoichiometric relationship, conditions that might be altered in TRPC-overexpressing cells [15] , which supports the importance of experiments in cells endogenously expressing TRPC proteins.
In HEK (human embryonic kidney)-293 cells expressing TRPC3, TRPC6 and the three Orai isoforms, interaction of Orai proteins with both TRPC proteins has been reported to confer on them the ability to respond to store depletion [16] .
In the present study we have investigated the interaction of endogenously expressed hTRPC6 with components of the CCE and NCCE pathways under resting conditions and upon store depletion either by pharmacological tools or the physiological agonist thrombin, or after stimulation with the DAG analogue OAG (1-oleoyl-2-acetyl-sn-glycerol). Our results indicate that Ca 2+ -store depletion stimulates a rapid interaction between entry; DAG, diacylglycerol; ECL, enhanced chemiluminescence; ER, endoplasmic reticulum; fura 2/AM, fura 2 acetoxymethyl ester; HBS, Hepes-buffered saline; NCCE, non-CCE; OAG, 1-oleoyl-2-acetyl-sn-glycerol; PM, plasma membrane; PRP, platelet-rich plasma; SERCA, sarcoplasmic/endoplasmic reticulum Ca 2+ -ATPase; STIM1, stromal interaction molecule 1; TBST, Tris-buffered saline with 0.1 % Tween 20; TG, thapsigargin; TPEN, N,N,N ,N -tetrakis-(2-pyridylmethyl)-ethylenediamine; TRPC, canonical transient receptor potential; hTRPC, human TRPC. 1 To whom correspondence should be addressed (email jarosado@unex.es).
hTRPC6 and both Orai1 and STIM1, whereas stimulation with the NCCE inducer OAG evokes the displacement of hTRPC6 from the CCE pathway and promotes its interaction with the NCCE Ca 2+ -permeable channel, hTRPC3. 
MATERIALS AND METHODS

Materials
Platelet preparation
Fura-2-loaded platelets were prepared as previously described [17] , and the method was approved by Local Ethical Committees and carried out in accordance with the Declaration of Helsinki. Briefly, blood was obtained from healthy drug-free volunteers and mixed with a one-sixth volume of acid/citrate dextrose anticoagulant containing 85 mM sodium citrate, 78 mM citric acid and 111 mM D-glucose. PRP (platelet-rich plasma) was then prepared by centrifugation for 5 min at 700 g and aspirin (100 μM) and apyrase (40 μg/ml) were added. PRP was incubated at 37
• C with 2 μM fura 2/AM for 45 min. Cells were then collected by centrifugation at 350 g for 20 min and resuspended in HBS [Hepes-buffered saline; 145 mM NaCl, 10 mM Hepes, 10 mM D-glucose, 5 mM KCl and 1 mM MgSO 4 (pH 7.45)], supplemented with 0.1 % BSA and 40 μg/ml apyrase.
Cell viability
Cell viability was assessed using calcein and Trypan Blue. For calcein loading, cells were incubated for 30 min with 5 μM calcein/AM at 37
• C, centrifuged (350 g for 20 min) and the pellet was resuspended in fresh HBS. Fluorescence was recorded from 2 ml aliquots using a Cary Eclipse Spectrophotometer (Varian). Samples were excited at 494 nm and the resulting fluorescence was measured at 535 nm. The results obtained with calcein were confirmed using the Trypan Blue exclusion technique. Fluorescence was recorded from 2 ml aliquots of magnetically stirred platelet suspension (2 × 10 8 cells/ml) at 37
• C using a fluorescence spectrophotometer with excitation wavelengths of 340 and 380 nm and emission at 505 nm. Changes in [Ca 2+ ] c were monitored using the fura 2 340/380 fluorescence ratio and, when TPEN was absent, calibrated according to the method of Grynkiewicz et al. [18] . Ca 2+ entry was estimated using the integral of the rise in [Ca 2+ ] c for 2.5 min after addition of CaCl 2 [19] . Control experiments were performed for all experimental procedures in order to correct the amount of Ca 2+ entry (integrals) by subtraction of the integral of the [Ca 2+ ] c elevation due to leakage of the indicator. Ca 2+ release from the intracellular stores was estimated using the integral of the rise in [Ca 2+ ] c for 3 min after the addition of thrombin.
Reversible electroporation procedure
The platelet suspension was transferred to an electroporation chamber containing antibodies at a final concentration of 2 μg/ml, and the antibodies were transjected as described previously [4, 20] . Reversible electropermeabilization was performed at 4 kV/cm at a setting of 25 μF capacitance and was achieved by seven pulses using a Bio-Rad Gene Pulser Xcell Electroporation System. Following electroporation, cells were incubated with antibodies for an additional 60 min at 37
• C then were centrifuged at 350 g for 20 min and resuspended in HBS containing 200 μM CaCl 2 . At the time of experiment, 250 μM EGTA was added.
Immunoprecipitation and Western blot analysis
The immunoprecipitation and Western blot analysis were performed as described previously [21] . Briefly, 500 μl aliquots of platelet suspension (2 × 10 9 cell/ml) were lysed with an equal volume of RIPA buffer (pH 7.2), containing 316 mM NaCl, 20 mM Tris/HCl, 2 mM EGTA, 0.2 % SDS, 2 % sodium deoxycholate, 2 % Triton X-100, 2 mM Na 3 VO 4 , 2 mM PMSF, 100 μg/ml leupeptin and 10 mM benzamidine. Aliquots of platelet lysates (1 ml) were immunoprecipitated by incubation with 2 μg of anti-Orai1, anti-TRPC3 or anti-TRPC6 antibody and 25 μl of Protein A-agarose overnight at 4
• C on a rocking platform. The immunoprecipitates were resolved by SDS/PAGE (10 % gel) and separated proteins were electrophoretically transferred on to nitrocellulose membranes for subsequent probing. Blots were incubated overnight with 10 % (w/v) BSA in TBST [Tris-buffered saline (20 mM Tris and 137 mM NaCl, pH 7.6) with 0.1 % Tween 20] to block residual protein-binding sites. Immunodetection of STIM1, hTRPC3, hTRPC6 and Orai1 was achieved using the anti-STIM1 antibody diluted 1:250 in TBST for 2 h or the anti-hTRPC3, antihTRPC6 or anti-Orai1 antibody diluted 1:1000 in TBST for 2 h respectively. The primary antibody was removed and blots were washed six times for 5 min each with TBST. To detect the primary antibody, blots were incubated for 45 min with horseradish peroxidase-conjugated donkey anti-goat IgG antibody, horseradish peroxidase-conjugated rabbit anti-mouse IgG antibody or horseradish peroxidase-conjugated goat anti-rabbit IgG antibody diluted 1:10 000 in TBST, and then exposed to ECL reagents for 4 min. Blots were then exposed to photographic films. The density of bands on the film was measured using scanning densitometry. Data were normalized to the amount of protein recovered by the antibody used for the immunoprecipitation.
Statistical analysis
Analysis of statistical significance was performed using one-way ANOVA. For comparison between two groups a Student's t test was used. P < 0.05 was considered to be significant.
RESULTS hTRPC6 co-immunoprecipitates with STIM1 and Orai1 in human platelets
A role for endogenously expressed hTRPC6 in agonist-induced Ca 2+ entry has been demonstrated in human platelets [4, 12] . We have now investigated the association between hTRPC6 and both
Figure 1 Time-course of thrombin-induced hTRPC6 co-immunoprecipitation with STIM1 and Orai1 in human platelets
Human platelets (2 × 10 9 cells/ml) were suspended in a Ca 2+ -free medium (100 μM EGTA added) and then stimulated for various periods of time (10-60 s) with thrombin (1 unit/ml) and lysed. Whole-cell lysates were immunoprecipitated (IP) with anti-hTRPC6 (A and B), anti-STIM1 (C) or anti-Orai1 (D) antibody (ab). Immunoprecipitates were subjected to SDS/PAGE (10 % gel) and subsequent Western blot analysis (WB) with a specific anti-STIM1 (A), anti-Orai1 (B) or anti-hTRPC6 (C and D) antibody. Membranes were reprobed with the antibody used for immunoprecipitation as the protein loading control. The panels show one result as a representative of five experiments. Molecular masses indicated on the right-hand side were determined using molecular-mass markers run on the same gel. Histograms represent the quantification of the hTRPC6-STIM1 association (A) or the hTRPC6-Orai1 association (B) in resting (control) and thrombin-treated cells. Results are presented as arbitrary optical density units and expressed as means + − S.E.M. *P < 0.05 compared with the control.
STIM1 and Orai1, by looking for co-immunoprecipitation from platelet lysates. Immunoprecipitation and subsequent SDS/PAGE and Western blot analysis were conducted using resting platelets and platelets stimulated in the absence of extracellular Ca 2+ (100 μM EGTA was added to the extracellular medium) with the physiological agonist thrombin (1 unit/ml) or with the inhibitor of SERCA (sarcoplasmic/endoplasmic reticulum Ca 2+ -ATPase) TG (1 μM), plus a low concentration of ionomycin (50 nM), to induce extensive depletion of the intracellular stores in platelets [22] . After treatment with these agents, cell viability in our platelet preparations was estimated as 95 %. After immunoprecipitation with an anti-hTRPC6 antibody, Western blotting with an anti-STIM1 antibody revealed a band between 84 and 90 kDa (the predicted molecular mass of STIM1 [23] ) in samples from resting platelets ( Figure 1A , upper panel). Treatment with thrombin increased the association between STIM1 and hTRPC6 in a timedependent manner, reaching a maximal effect after 30 s of platelet stimulation ( Figure 1A , upper panel; n = 6). In addition, we have investigated the possible interaction between hTRPC6 and Orai1. After immunoprecipitation with an anti-hTRPC6 antibody, Western blotting with an anti-Orai1 antibody revealed a band of approx. 45 kDa (the predicted molecular mass of Orai1 [24] ) in samples from resting platelets ( Figure 1B, upper panel) . Treatment with thrombin enhanced the co-immunoprecipitation of hTRPC6 with Orai1 in a time-dependent manner ( Figure 1B , upper panel; n = 6). Similar results were observed when cells were stimulated with TG + ionomycin, which increased coimmunoprecipitation of hTRPC6 with STIM1 and Orai1 in a time-dependent manner, reaching a maximum after 10 s of stimulation, and then was sustained for at least 60 s (Figures 2A  and 2B , upper panel; n = 6). We also conducted converse experiments, immunoprecipitating platelet lysates with anti-STIM1 or anti-Orai1 antibodies and detecting for the presence of hTRPC6, a protein of approx. 100 kDa [25] . Human platelets (2 × 10 9 cells/ml) were suspended in a Ca 2+ -free medium (100 μM EGTA added) and then stimulated for various periods of time (10-60 s) with TG (1 μM) + ionomycin (Iono; 50 nM) and lysed. Whole-cell lysates were immunoprecipitated (IP) with anti-hTRPC6 (A and B), anti-STIM1 (C) or anti-Orai1 (D) antibody (ab) and immunoprecipitates were subjected to SDS/PAGE (10 % gel) and subsequent Western blot analysis (WB) with a specific anti-STIM1 (A) anti-Orai1 (B) or anti-hTRPC6 (C and D) antibody. Membranes were reprobed with the antibody used for immunoprecipitation as the protein loading control. The panels show one result as a representative of five experiments. Molecular masses indicated on the right-hand side were determined using molecular-mass markers run on the same gel. Histograms represent the quantification of the hTRPC6-STIM1 association (A) or the hTRPC6-Orai1 association (B) in resting (control) and thrombin-treated cells. Results are presented as arbitrary optical density units and expressed as means + − S.E.M. *P < 0.05 compared with the control.
for TG + ionomycin at 10, 30 and 60 s respectively ( Figures 1C,  1D , 2C and 2D, upper panels). Western blotting of the same membranes with the antibody used for immunoprecipitation confirmed similar protein content in all lanes (Figures 1 and  2 , lower panels). No specific proteins were detected when immunoprecipitation was performed using a non-specific rabbit IgG control. Only the heavy chain of the rabbit IgG used for immunoprecipitation was detected when a horseradish peroxidase-conjugated anti-rabbit IgG antibody was used as a secondary antibody in lanes 3-5 (Supplementary Figure S1 at http://www.BiochemJ.org/bj/420/bj4200267add.htm).
hTRPC6 is involved in TPEN-mediated Ca 2+ entry TPEN may be a useful tool to investigate the mechanism of CCE due to its ability to reduce the intraluminal free Ca 2+ concentration. The use of TPEN avoids potential confounders, such as changes in cytosolic Ca 2+ and second messenger levels, secondary to stimulation with agonists, as well as the use of pharmacological inhibitors of SERCA, which has been suggested to play a role in CCE [26] . In a Ca 2+ -free medium, treatment of fura-2-loaded human platelets with thrombin (1 unit/ml) in stirred cuvettes at 37 entry) [28] , due to in situ chelation of Ca 2+ in the intracellular stores ( Figure 3A , upper graph; n = 5). The elevation in fura 2 fluorescence ratio observed after the addition of Ca 2+ to the medium in the presence of TPEN was clearly greater than that observed in the absence of TPEN ( Figure 3A , lower graph; n = 5). In the presence of TPEN, thrombin-evoked Ca 2+ release and entry were significantly reduced ( Figure 3A, upper graph) , a phenomenon that is probably not attributed to a decrease in cell viability (95 % of cells were viable in our platelet preparations treated with TPEN, at least during the performance of the experiments). (A) Fura-2-loaded human platelets were suspended in a Ca 2+ -free medium (100 μM EGTA was added) and treated with TPEN (500 μM; upper graph) or the vehicle (DMSO, lower graph), as a control. Platelets were stimulated with 1 unit/ml thrombin (upper graph) or the vehicle (HBS, lower graph) 1 min later, followed by the addition of CaCl 2 (final concentration 300 μM) 3 min later to initiate Ca 2+ entry. (B) Human platelets were electropermeabilized in a Gene Pulser as described in the Materials and methods section and then were incubated in the presence of 1 μg/ml anti-hTRPC6 antibody, anti-hTRPC3 antibody, both or 1 μg/ml rabbit or goat IgG (Control, upper and lower graph) for 60 min as indicated. Cells were then stimulated in a Ca 2+ -free medium (250 μM EGTA was required since electroporated cells were suspended in medium containing 200 μM CaCl 2 , see the Materials and methods section) with 500 μM TPEN (upper graph) or the vehicle (DMSO, lower graph) and 3 min later CaCl 2 (1 mM) was added to the medium to initiate Ca 2+ entry. The traces are representative of five independent experiments.
To investigate the involvement of hTRPC6 in TPEN-mediated CCE we have induced functional knockdown of hTRPC6 by electrotransjection of cells with an anti-hTRPC6 antibody, directed towards an intracellular C-terminal sequence, following a previously described procedure [4] . Platelet viability after reversible electroporation was 90 %; therefore experimental cells and controls were treated in the same way, except for the antibody electrotransjected (anti-hTRPC3 or hTRPC6 antibodies in experimental cells and a non-specific rabbit IgG in controls). We have recently reported that platelet incubation with the anti-hTRPC6 antibody reduced Ca 2+ and Mn 2+ entry induced by thrombin, TG or 2,5-di-(t-butyl)-1,4-hydroquinone, thus suggesting a role for hTRPC6 in CCE [4] . In the present study we show for the first time that electrotransjection with 1 μg/ml hTRPC6 significantly reduced TPEN-evoked CCE by 33 + − 6 % compared with controls (cells electrotransjected with 1 μg/ml goat IgG; Figure 3B , upper graph; P < 0.05, n = 5). We have further explored the role of hTRPC3 in CCE induced by TPEN by electrotransjection of cells with an anti-hTRPC3 antibody directed towards the intracellular N-terminal sequence. As shown in the upper graph of Figure 3(B) , TPEN-evoked CCE was not modified in cells electrotransjected with 1 μg/ml anti-hTRPC3 antibody compared with platelets electrotransjected with 1 μg/ml rabbit IgG. Finally, we found that electrotransjection of the anti-hTRPC6 antibody in combination with the anti-hTRPC3 antibody reduced CCE by TPEN to a similar extent as the anti-hTRPC6 antibody alone ( Figure 3B , upper graph).
As described in the Materials and methods section, the amount of Ca 2+ entry was corrected by subtraction of the elevation in [Ca 2+ ] c observed after the addition of Ca 2+ in cells treated with vehicle instead of thrombin and/or TPEN ( Figures 3A and 3B , lower graphs).
Ca
2+ -dependent association of hTRPC6 and hTRPC3
We have further investigated the interaction between hTRPC6 and hTRPC3 upon stimulation with thrombin or TG + ionomycin.
Immunoprecipitation with an anti-hTRPC6 antibody followed by Western blotting with an anti-hTRPC3 antibody revealed a band of approx. 100 kDa (the predicted molecular mass of hTRPC3 [29] ), which indicates association of both hTRPC proteins in resting platelets (Figure 4 , upper panels). In the absence of extracellular Ca 2+ , platelet stimulation with thrombin or extensive Ca 2+ -store depletion, induced by TG + ionomycin, enhanced coimmunoprecipitation between hTRPC6 and hTRPC3 (Figures 4A and 4B, upper panels; P < 0.05). This effect was abolished by platelet loading with the intracellular Ca 2+ chelator dimethyl-BAPTA [1,2-bis-(o-aminophenoxy)ethane-N,N,N ,N -tetra-acetic acid], which prevents thrombin-, as well as TG + ionomycininduced Ca 2+ elevations in [Ca 2+ ] c ( Figures 4C-4F ). Similar results were observed when converse experiments were conducted, immunoprecipitating platelet lysates with an antihTRPC3 antibody and detecting for the presence of hTRPC6. Treatment with thrombin or TG + ionomycin enhanced the association of hTRPC6 with hTRPC3 by 142 + − 8 and 151 + − 11 % of control respectively ( Figures 4A and 4B, lower panels) . This event was prevented by BAPTA loading ( Figures 4E and 4F, lower  panels) .
Interestingly, we have found that OAG, a DAG analogue that activates NCCE, attenuates the association between hTRPC6 and both Orai1 and STIM1, as detected by immunoprecipitation of platelet lysates with an anti-hTRPC6 antibody followed by Western blotting with anti-Orai1 or anti-STIM1 antibodies ( Figures 5A and 5B , upper panels; P < 0.05), as well as by converse experiments (Figures 5A and 5B, lower panels; P < 0.05). In the absence of extracellular Ca 2+ , OAG was unable to induce association between hTRPC6 and hTRPC3 ( Figure 5C ). In contrast, in the presence of 1 mM extracellular Ca 2+ , OAG significantly enhanced association between both hTRPC proteins ( Figure 5D ; P < 0.05). Western blotting of the same membranes with the anti-hTRPC6 antibody confirmed comparable amounts of protein in all lanes (Figures 4 and 5) . Control (A and B) and dimethyl-BAPTA-loaded (E and F) human platelets (2 × 10 9 cells/ml) were suspended in a Ca 2+ -free medium (100 μM EGTA added) and then stimulated for 30 s with thrombin (1 unit/ml; A and E) or TG (1 μM) + ionomycin (50 nM; B and F) and lysed. Whole-cell lysates were immunoprecipitated (IP) with anti-hTRPC6 antibody (A, B, E and F, upper panels) or anti-hTRPC3 antibody (A, B, E and F, lower panels) and immunoprecipitates were subjected to SDS/PAGE (10 % gel) and subsequent Western blot analysis (WB) with a specific anti-hTRPC6 (upper panels) or anti-hTRPC3 (lower panels) antibody. Membranes were reprobed with the antibody used for immunoprecipitation for the protein loading control. The panels show one result as a representative of five experiments. Molecular masses indicated on the right-hand side were determined using molecular-mass markers run in the same gel. Histograms represent the quantification of the hTRPC6-hTRPC3 association in resting (control) and stimulated cells. Results are presented as arbitrary densitometric units and expressed as means + − S.E.M. *P < 0.05 compared with the control. (C and D) Human platelets were incubated at 37 • C for 30 min in the presence or absence of 10 μM dimethyl-BAPTA, as indicated. At the time of experiment, 100 μM EGTA was added. Cells were then stimulated with 1 unit/ml thrombin (C) or 1 μM TG + 50 nM ionomycin (D). Elevations in [Ca 2+ ] c were monitored using the 340/380 nm ratio as described in the Materials and methods section. Traces shown are representative of five independent experiments ab, antibody; Iono, ionomycin.
As shown in the upper graph of Figure 5 (E), treatment of platelets in a Ca 2+ -free medium with 100 μM OAG did not increase [Ca 2+ ] c ; subsequent addition of Ca 2+ to the external medium resulted in a rise in [Ca 2+ ] c , greater than that induced in cells treated with vehicle alone ( Figure 5E , lower graph), indicative of NCCE. Electrotransjection with 1 μg/ml hTRPC3 or hTRPC6 significantly reduced OAG-evoked NCCE by 40 + − 9 and 56 + − 2 % respectively ( Figures 5G and 5H ) compared with controls [cells electrotransjected with 1 μg/ml rabbit IgG; Figure 5F (α-mouse IgG); P < 0.05, n = 5]. Taken together, these findings suggest that the association of hTRPC6 and hTRPC3 induced by OAG is mediated by a Ca 2+ -dependent mechanism, as previously described for the association between both proteins stimulated by thrombin or TG + ionomycin.
Treatment with TG + ionomycin is unable to induce association of hTRPC3 with hTRPC1, STIM1 or Orai1
We have further investigated the possible interaction between hTRPC3 and hTRPC1, STIM1 and Orai1, which form a dynamic complex involved in CCE [30] , upon stimulation with TG + ionomycin. Immunoprecipitation with an anti-hTRPC3 antibody followed by Western blotting with an anti-hTRPC1 antibody revealed a faint band of approx. 100 kDa (the predicted molecular mass of hTRPC1 [31, 32] ), which indicates certain association of both hTRPC proteins in resting platelets ( Figure 6A , upper panel; n = 5). After platelet stimulation with TG + ionomycin the amount of hTRPC1 immunoprecipitated with the antihTRPC3 antibody was not significantly different from than (A-D) Human platelets (2 × 10 9 cells/ml) were suspended in a Ca 2+ -free medium (100 μM EGTA added; A-C) or in a medium containing 1 mM CaCl 2 (D) and then stimulated for 30 s with OAG (100 μM) and lysed. Whole-cell lysates were immunoprecipitated (IP) with an anti-hTRPC6 antibody and immunoprecipitates were subjected to SDS/PAGE (10 % gels) and subsequent Western blot analysis (WB) with a specific anti-hTRPC6 (A-D, upper panels), anti-Orai1 (A, lower panel), anti-STIM1 (B, lower panel) or anti-hTRPC3 (C and D, lower panels) antibody (ab). Membranes were reprobed with the antibody used for immunoprecipitation as the protein loading control. The panels show one result as a representative of five experiments. Molecular masses indicated on the right-hand side were determined using molecular-mass markers run in the same gel. Histograms represent the quantification of the association of hTRPC6 with Orai1 (A), STIM1 (B) and hTRPC3 (C and D) in resting (control) and OAG-stimulated cells. Results are presented as arbitrary densitometric units and expressed as means + − S.E.M. *P < 0.05 compared with the control. (E-H) Human platelets were electropermeabilized in a Gene Pulser as described in the Materials and methods section and then were incubated in the absence (E) or presence (G) of 1 μg/ml anti-hTRPC6 antibody, anti-hTRPC3 antibody (H), or rabbit anti-mouse IgG (F) for 60 min as indicated. Platelets were suspended in a Ca 2+ -free medium (250 μM EGTA was added) and stimulated with OAG [100 μM; E (upper graph), F, G and H] or the vehicle (DMSO; E, lower graph), as control, followed by the addition of CaCl 2 (final concentration 1 mM) 3 min later to initiate Ca 2+ entry.
observed in resting cells ( Figure 6A , upper panel). No protein with the predicted molecular mass of STIM1 or Orai1 was detected in hTRPC3 immunoprecipitates either in resting or in TG + ionomycin-stimulated cells ( Figures 6B and 6C , upper panels; n = 5). Similar results were observed when converse experiments were conducted immunoprecipitating platelet lysates with anti-hTRPC1, anti-STIM1 or anti-Orai1 antibodies and detecting for the presence of hTRPC3 ( Figure 6 , lower panels).
DISCUSSION
TRPC proteins have been shown to participate in both CCE and NCCE influx [15] . hTRPC6 has long been proposed as a candidate to mediate NCCE in different cell types [11, 33, 34] , including human platelets [12] . In these cells, we have recently suggested that hTRPC6 might also be involved in the conduction of CCE on the basis of the inhibitory effect of electrotransjection of the anti-hTRPC6 antibody on TG-induced Ca 2+ entry [4] . CCE is a mechanism for Ca 2+ influx regulated by the Ca 2+ content of the intracellular stores rather than by the Ca 2+ signals generated by agonists or pharmacological tools such as TG [35] . In the present study we have further observed the involvement of hTRPC6 in CCE by using TPEN, an TG, which confirms previous results [4] . We have found that hTRPC3, which has been shown to conduct CCE in a number of cell types [36, 37] but NCCE in others [38, 39] , is not required for Ca 2+ entry induced by TPEN, as demonstrated by electrotransjection of the anti-hTRPC3 antibody, which further suggests that treatment with TPEN induces CCE in human platelets. The specificity of electrotransjection with antibodies has been explored by testing the effect of incubation with an antibody directed to a protein not related to hTRPC6 or hTRPC3 proteins or any other platelet protein. We have used goat or rabbit IgG since these are the natures of the anti-hTRPC6 and anti-hTRPC3 antibodies respectively.
Thrombin-evoked Ca 2+ release and entry were significantly reduced in the presence of TPEN. TPEN has been shown to cause a rapid decrease in [Ca 2+ ] s [40] , where the Ca 2+ concentration is elevated (∼ 0.2-1 mM [41] ), which might explain the significant reduction of the extent of Ca 2+ release-induced thrombin. The inhibitory effect of TPEN on Ca 2+ entry mediated by thrombin might be partially attributed to its chelating effects and to the known activation of Ca 2+ extrusion through the Na + -Ca 2+ exchanger [42] . CCE has been shown to require a dynamic interplay between the ER Ca 2+ sensor STIM1 and the PM channels Orai1 and hTRPC1 [7] . In human platelets we have recently reported that Orai1 mediates the communication between STIM1 and hTRPC1, which is essential to confer hTRPC1 properties of the CCE channel [8] . In the present paper we describe, for the first time, evidence for the interaction between endogenously expressed hTRPC6 and both Orai1 and STIM1 in platelets. The association between these proteins was detected in resting platelets and enhanced by the physiological agonist thrombin or extensive store depletion using TG + ionomycin. The interaction between hTRPC6 and both Orai1 and STIM1 was found to be independent of extracellular Ca 2+ and might mediate the involvement of hTRPC6 in CCE in these cells.
On the basis that hTRPC6 and hTRPC3 have been shown to be involved in NCCE and that both channels have been reported to be associated with the same platelet membrane regions [43] , we have explored the interaction between both proteins upon stimulation with thrombin or TG + ionomycin and OAG, a DAG analogue that activates NCCE [4] . Platelet treatment with thrombin or TG + ionomycin enhances the interaction between hTRPC6 and hTRPC3 only when rises in [Ca 2+ ] c are allowed, a response that was abolished by cell loading with dimethyl-BAPTA. Since CCE was first proposed as a mechanism for Ca 2+ influx regulated by the Ca 2+ content of the intracellular stores rather than by the Ca 2+ signals generated by agonists [35] , our findings suggest that this interaction is non-capacitative in nature due to its dependence on rises in [Ca 2+ ] c . Similarly, stimulation with OAG increases the association of hTRPC6 with hTRPC3 when Ca 2+ entry is allowed, suggesting that this interaction is Ca 2+ -dependent. In addition, this finding suggests that a different mechanism mediates the initial Ca 2+ entry step activated by OAG. Interestingly, treatment with OAG decreased the interaction of hTRPC6 with Orai1 and STIM1, which indicates that activation of NCCE pathways results in displacement of hTRPC6 from the CCE protein complex to the NCCE mechanism. To further support the role of hTRPC3 in NCCE we have found that store depletion with TG + ionomycin did not induce association between hTRPC3 with hTRPC1, STIM1 or Orai1.
The present study suggests that hTRPC6 interacts with the CCE channel protein Orai1 and the ER Ca 2+ sensor STIM1 upon stimulation with the physiological agonist thrombin or extensive Ca 2+ -store depletion. hTRPC6 is required for CCE induced either by TG [4] or TPEN, which induces a decrease in [Ca 2+ ] s , but avoiding rises in [Ca 2+ ] c . The NCCE activator OAG displaces hTRPC6 from Orai1 and STIM1 and induces its association with hTRPC3. We propose that depletion of [Ca 2+ ] s induces the formation of a macromolecular complex involving PM Ca 2+ -permeable channels such as Orai1, hTRPC6 and hTRPC1 [8] . In contrast, activation of NCCE results in displacement of hTRPC6 from the CCE pathway and favours Ca 2+ -dependent association between hTRPC6 and hTRPC3 (a schematic diagram of the proposed model is shown in Figure 7 ). These results support the hypothesis that hTRPC6 participates in CCE and NCCE pathways in human platelets by association with different Ca 2+ -handling proteins.
